Compare Cronos Group Inc (CRON) vs General Motors Company (GM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs General Motors Company — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while General Motors Company trades at $82.5 (market cap $71.06B). The key difference: General Motors Company is far larger — about 59.2× Cronos Group Inc's market cap, and General Motors Company pays a 0.89% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and General Motors Company for 83 Days on average.
| CRON | GM | |
|---|---|---|
Market Cap | $1.20B | $71.06B |
Volume | 450,387 | 6,269,264 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $90.30 |
52-Week Low | $2.30 | $55.35 |
Typical Hold Time | 22 Days | 83 Days |
Enterprise Value | $401.73M | $174.04B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
General Motors (GM) trades at $82.25, up 0.29% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with declining revenue and net income margins (1.05% in 2025) but attractive valuation ratios including P/S of 0.41. Recent news highlights competitive pressures as Toyota narrows the U.S. sales gap and Q3 2026 sales fell 5.5% amid EV challenges.
GM faces headwinds from market share erosion and profitability pressure, though analyst consensus remains bullish with a $102.08 price target. Investment appeal hinges on execution amid industry transition, with risks including high debt levels and competitive threats from Asian automakers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →
